tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Arcturus Therapeutics: Promising Developments and Strong Financial Position Justify Buy Rating
PremiumRatingsArcturus Therapeutics: Promising Developments and Strong Financial Position Justify Buy Rating
3M ago
Arcturus Therapeutics Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Arcturus Therapeutics Earnings Call: Progress Amid Challenges
3M ago
Arcturus Therapeutics price target lowered to $72 from $140 at Piper Sandler
Premium
The Fly
Arcturus Therapeutics price target lowered to $72 from $140 at Piper Sandler
3M ago
Arcturus Therapeutics Advances Cystic Fibrosis Study with ARCT-032
PremiumCompany AnnouncementsArcturus Therapeutics Advances Cystic Fibrosis Study with ARCT-032
3M ago
Arcturus Therapeutics Advances with ARCT-810 Study for OTC Deficiency
Premium
Company Announcements
Arcturus Therapeutics Advances with ARCT-810 Study for OTC Deficiency
3M ago
Cathie Wood Trims Exposure to AMD and Other U.S. Tech Favorites, Doubles Down on Baidu and Biotech Plays
Premium
Market News
Cathie Wood Trims Exposure to AMD and Other U.S. Tech Favorites, Doubles Down on Baidu and Biotech Plays
3M ago
LendingClub upgraded, Enphase Energy downgraded: Wall Street’s top analyst calls
PremiumThe FlyLendingClub upgraded, Enphase Energy downgraded: Wall Street’s top analyst calls
3M ago
Arcturus Therapeutics downgraded to Neutral from Buy at Citi
Premium
The Fly
Arcturus Therapeutics downgraded to Neutral from Buy at Citi
3M ago
Arcturus Therapeutics price target lowered to $20 from $42 at Wells Fargo
Premium
The Fly
Arcturus Therapeutics price target lowered to $20 from $42 at Wells Fargo
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100